Pinki Mishra, Rizwana Parveen, Reema Singh, Shiekh Raisuddin, Nidhi B

Slides:



Advertisements
Similar presentations
The Research Question Alka M. Kanaya, MD Associate Professor of Medicine, Epidemiology & Biostatistics UCSF October 3, 2011.
Advertisements

METHODS Systematic review of evidenced-based medicine.Systematic review of evidenced-based medicine. A review of the literature was done using a combined.
Low 25-Hydroxyvitamin D and Risk of Type 2 Diabetes: A Prospective Cohort Study and Meta-analysis S. Afzal, S.E. Bojesen, and B.G. Nordestgaard February.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J CLIN ENDOCRINOL METAB, 97, , 2012.
Personalised Eye Consultation (PEC) to improve outcomes in DR Dr Eva Fenwick (Research Fellow) Behavioural Research in Ophthalmology Prue Spencer, Project.
Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.
Reem Sallam, MD, MSc. PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Dr. Amr S. Moustafa, MD, PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
The Sun Exposure and Vitamin D Supplementation (SEDS) study Dr Sam Hoare National Centre for Epidemiology and Population Health.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Sifting through the evidence Sarah Fradsham. Types of Evidence Primary Literature Observational studies Case Report Case Series Case Control Study Cohort.
A R ETROSPECTIVE R EVIEW OF THE IMPLEMENTATION OF A VITAMIN D SUPPLEMENTATION POLICY IN CHILDREN WITH CHRONIC RENAL IMPAIRMENT. Sandra H. Geraghty, Clinical.
Authors: Dr. Majid Valizadeh Dr. Zahra Piri Dr. Kourosh Kamali Dr. Farnaz Mohammadian Dr. Hamidreza Amirmioghadami Presenter: Piri Z. MD.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Insulin Therapy for Type 2 Diabetes Mellitus JAMA.
DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.
Regression coefficient (b) RESULTS AND DISCUSSION
III. Endocrine Pancreas Diabetes Mellitus
Prof. Sahar A Hammouda, Prof. Ahmed A Mohamedin Taibah University
Bilingualism or multilingualism has protective effect on dementia onset: is there any evidence? A systematic review Yadav AK, Yadav J, Kumar P, Sagar R,
Diabetes and Hypertension Health Screening in the Fresno Sikh Population: A Cross Sectional Approach Baljit Singh Dhesi 1,2 1University of California,
Actual and Potential Drug Related Problems in Diabetic Patients through Medication Reconciliation Process Presented in Indonesian – Japan Joint Scientific.
Use of Insulin Pump in Children with Type I Diabetes Mellitus: Effect on glycemic control and Body Mass Indices (BMI). Noura Al Hemaidi, Maryam Al Ali,
Estimation of blood glucose in diabetes mellitus
Metabolic Changes in Diabetes Mellitus
Chi-Wei Lin, I-Ting Liu, Ru-Yi Huang, Wei-Chieh Hung, Ching-Jung Ho
Yoga in Sexual Dysfunctions
Metabolic Changes in Diabetes Mellitus
HEALTH PROMOTION, INTEGRAL CARE AND SOCIAL INCLUSION
Herbal medicines in poorly controlled diabetes: A Systematic Review
Figure 5. Treatment of the checkpoint inhibitor related toxicity
To compare demographic and clinical characteristics of those with and without diabetes that undergo a lower extremity amputation in Glasgow, UK Fiona.
Long –Term Developmental Outcomes in Preterm Neonates Exposed to Hyperglycemia Camila Goldner Pérez, Judy Saslow MD, Vilmaris Quiñones Cardona MD, Elizabeth.
Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program Cardiorenal Med 2011;1:45–52 - DOI: /
Burden of Type 1 Diabetes
Miss.Shuchismita Behera Miss.Sujata Dixit Dr.G.Bulliyya Dr.S.K.Kar
Sumaiyah Mat1, Mohamad Hasif Jaafar1, Tan Maw Pin1,2
Table 1: Demographics and Patient Characteristics
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2017 American Academy of Pediatrics.
Presenter : For : Dr. Dhananjay Gupta API-DSC 2016
Metabolic Changes in Diabetes Mellitus
Perceived Caregiver Stress in Alzheimer’s disease and Mild Cognitive Impairment Vikas Dhikav, Pinki Mishra, Arjun Kumar Singhal*, Dolly Prajapati**, Kuljeet.
Jagadesh M ,SURYA NARAYANA J, JAYAPRAKASH, NRRAU
D2d participating clinical sites
Presenter: Wen-Ching Lan Date: 2018/08/01
Macrovascular Complications Microvascular Complications
Diabetes and Bone: the model of GIO
Nat. Rev. Endocrinol. doi: /nrendo
Emerging Mechanisms in Glucose Metabolism
The prevalence of diabetes (A), impaired glucose tolerance (B), impaired fasting glucose (C), and impaired glucose metabolism (D) among those with Finnish.
Disease Progression in Type 2 Diabetes
Flowchart of literature search for the effect of fructose on glycemic end points (fasting glucose, fasting insulin, and glycated blood proteins [HbA1c.
Chapter 26 Endocrine Function
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway  Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki 
Glycemic Management in ESRD and Earlier Stages of CKD
Is Growth Hormone Resistance/IGF-1 Reduction Good for You?
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Conceptual model of the natural history of diabetic kidney disease.
Complementary Art Interventions for Children Coping with Cancer:
Comparison of (A) WC, (B) fasting glucose, (C) insulin, (D) HOMA-IR, (E) numbers of metabolic factors, and (F) prevalence of metabolic syndrome in relation.
Left columns: Plasma glucose and serum insulin concentrations, circulating TF-PCA, and FVIIa activity before and during 24 h of selective hyperglycemia.
Burden of Type 1 Diabetes
Surgical re-excision versus observation for histologically dysplastic nevi: a systematic review of associated clinical outcomes K.T. Vuong1, J. Walker2,
RBP4 and glucose metabolism.
This figure shows the inclusion and exclusion criteria used to derive the final analytic cohort of 2563 persons with diabetes from the initial 4915 persons.
Correlation between serum visfatin concentrations and the clinical stage (A) and tumor size (B, C) of HCCs. A and B, the correlations were determined by.
Pathophysiology and drug targets.
Presentation transcript:

EFFECT OF A MICRONUTRIENT ON A DIABETIC COMPLICATION: SYSTEMATIC REVIEW Pinki Mishra, Rizwana Parveen, Reema Singh, Shiekh Raisuddin, Nidhi B. Agarwal Centre for Translational and Clinical Research, Jamia Hamdard, New Delhi-110062, INDIA Introduction Results Vitamin D levels were assessed and compared among control groups and in patients with and without retinopathy in the studies included in this systematic review. Serum vitamin D level was negatively associated with diabetic retinopathy. Diabetes mellitus (DM) is a complex, chronic, progressive disease, of multiple aetiologies characterized by chronic hyperglycemia leads to a reduction in quality of life and life expectancy.1 Low vitamin D status has been associated with increased risk of non-musculoskeletal diseases such as cancer, diabetes and multiple sclerosis2 Albeit, the underlying biological mechanisms are poorly understood, the association of low levels of serum 25-hydroxyvitamin D3 [25(OH)D3] concentrations with DM2 may be mediated through effects on glucose homeostasis and direct effect of vitamin D on the β-cell function, and thus insulin secretion. Low vitamin D status has also been suggested to contribute insulin resistance and is associated with markers of impaired glucose metabolism, such as glycosylated hemoglobin.3 Moreover, an increased incidence of diabetic complications have been observed in DM2 patients with hypovitaminosis D. Figure:1 Vitamin D levels in controls and in patients with and without diabetic retinopathy Figure 2: Vitamin D levels in controls, patients with proliferative diabetic retinopathy and without diabetic retinopathy Methodology This systematic review was conducted to assess the association of hypovitaminosis D and DM2 complications. A literature search in PubMed and MEDLINE, was conducted for clinical trials assessing the levels of vitamin and correlating the levels with diabetes complications, by applying predetermined inclusion and exclusion criteria. Inclusion criteria Studies with Vitamin D Studies with retinopathy Studies with type-2 diabetes Exclusion criteria (n=61) -Studies on type 1 diabetes -Studies not related to diabetes retinopathy -Studies not assessing vitamin d levels -Pediatrics -Retrospective study -Studies reporting combined result on both type-1 and type-2 diabetes -Studies reporting combined data on complications of diabetes -Mean values of vitamin D levels not provided Figure 3: Prevalence of vitamin D deficiency among the controls and in n patients with and without diabetic retinopathy Figure 4 : Vitamin D levels in patients without retinopathy and in different grades of retinopathy4 Conclusion The findings from the systematic review indicate that low vitamin D level may be considered a predictor of diabetic retinopathy; however, data from longitudinal and large cohort studies are needed. It is suggested that the levels of vitamin should be periodically screened in diabetics. References American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2014;37(Suppl 1). J van der Schaft, HL Koek, E Dijkstra, HJJ Verhaar, YT van der Schouw et al. The association between vitamin D and cognition: A systematic review. Ageing Research Reviews. 2013;12:1013– 1023. Christine D, Maria SP, Pal W and Philippe G. vitamin D Status in Relation to Glucose Metabolism and Type 2 Diabetes in Septuagenarians Diabetes Care. 2011;34:1284–1288. Vitamin D deficiency increases the risk of retinopathy in Chinese patients with type 2 diabetes.He R, Shen J, Liu F, Zeng H, Li L, Yu H, Lu H, Lu F, Wu Q, Jia W. Diabet Med. 2014 Dec;31(12):1657-64